title: Vasodilatory effects of cinnamaldehyde and its mechanism of action in the rat aorta.
abstract: The vasodilatory effect of cinnamaldehyde was investigated for its mechanism of action using isolated rings of rat aorta. Cinnamaldehyde relaxed aortic rings precontracted with phenylephrine in a dose-dependent manner, was not affected by either the presence or removal of the endothelium. Pretreatment with NG-nitro-L-arginine methyl ester and 1H-[1,2,4]-oxadiazole-[4,3-a]-quinoxalin-1-one could not block vasodilation by cinnamaldehyde, indicating that nitric oxide signaling is not involved. Potassium channel blockers, such as glibenclamide, tetraethylammonium, and BaCl2, had no effect on the relaxation produced by cinnamaldehyde. In addition, treatment with either indomethacin or propranolol did not affect cinnamaldehyde-induced vasodilatation. On the other hand, pretreatment of endothelium-denuded rings with cinnamaldehyde significantly inhibited vasoconstriction induced by endogenous vasoconstrictors, including angiotensin II, 5-hydroxytryptamine, dopamine, endothelin-1, and phenylephrine. In a Ca2+-free experimental setting, this natural vasodilator not only blocked Ca2+ influx-dependent vasoconstriction by either phenylephrine or KCl, but also inhibited phenylephrine-induced tonic contraction, which relies on intracellular Ca2+ release. This study shows that endothelium-independent, Ca2+ influx and/or an inhibitory release mechanism contributes to the vasodilatory effect of cinnamaldehyde.
authors: Murad Research Institute for Modernized Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
authors: Yong-Liang
authors: YL
authors: Xue
authors: Hai-Xia
authors: HX
authors: Shi
authors: Ferid
authors: F
authors: Murad
authors: Ka
authors: K
authors: Bian
references: Front Biosci. 2003 Jan 01;8:d264-78
references: 12456375
references: Biol Pharm Bull. 2006 Dec;29(12):2415-8
references: 17142974
references: J Alzheimers Dis. 2009;17(3):585-97
references: 19433898
references: J Pharmacobiodyn. 1987 May;10(5):201-8
references: 3040960
references: Exp Neurol. 2009 Apr;216(2):420-7
references: 19166834
references: Thromb Res. 2007;119(3):337-42
references: 16626787
references: Int J Clin Exp Med. 2009 Oct 05;2(3):254-65
references: 19918318
references: Nat Rev Mol Cell Biol. 2003 Jul;4(7):517-29
references: 12838335
references: Biol Pharm Bull. 2008 Mar;31(3):426-30
references: 18310904
references: J Pharmacol Exp Ther. 1985 Mar;232(3):708-16
references: 2983068
references: J Clin Hypertens (Greenwich). 2008 Apr;10(4):304-10
references: 18401228
references: J Vasc Res. 1994 Sep-Oct;31(5):256-64
references: 7522594
references: J Cereb Blood Flow Metab. 1988 Dec;8(6):808-15
references: 3142891
references: Food Chem Toxicol. 2008 Jan;46(1):220-31
references: 17868967
references: Naunyn Schmiedebergs Arch Pharmacol. 1993 Aug;348(2):191-6
references: 7694155
references: Toxicol Appl Pharmacol. 2008 Jun 1;229(2):161-71
references: 18304597
references: Cancer Lett. 2009 Jun 18;278(2):174-182
references: 19203831